Spots Global Cancer Trial Database for EuroSIDA As An External Comparator To MOTIVATE Trials

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: EuroSIDA As An External Comparator To MOTIVATE Trials

Official Title: Incidence And Risk Factors For Acquired Immune Deficiency Syndrome (AIDS) Defining And Non-AIDS Defining Malignancies, And Other AIDS Defining Illnesses In The EuroSIDA Study

Study ID: NCT01329783

Conditions

HIV

AIDS

Interventions

maraviroc

Study Description

Brief Summary: Human Immunodeficiency Virus (HIV) infected patients who meet the entry criteria for the maraviroc pivotal trials (Maraviroc versus Optimized Therapy in Viremic Antiretroviral Treatment-Experienced Patients, MOTIVATE) will be identified from the EuroSIDA HIV cohort. The rates of specific clinical adverse events in this identified patient population will be compared with the rates of these events in the participants of the MOTIVATE trials.

Detailed Description: All patients in EuroSIDA cohort that meet the entry criteria of MOTIVATE trials are included without any sampling.